Opko Health (OPK) Cash from Discontinued Operations (2010 - 2012)
Opko Health (OPK) reported Cash from Discontinued Operations of 7000.0 for Q4 2012, up 97.51% on a YoY basis from 3544.14 in Q1 2012, and down 107.29% quarter-over-quarter from 96000.0 in Q3 2012.
Opko Health (OPK) Cash from Discontinued Operations (2010 - 2012) Analysis & Trends
Opko Health has reported Cash from Discontinued Operations for 3 years, with the latest figure at 7000.0 in Q4 2012.
- For the quarter ending Q4 2012, Cash from Discontinued Operations rose 97.51% year-over-year to 7000.0; the trailing twelve-month figure through Dec 2013 stood at 89000.0 (up 1171.43% YoY), and the FY2012 full-year result was 7000.0, up 100.15% from the prior year.
- Cash from Discontinued Operations for Q4 2012 stood at 7000.0, down from 96000.0 in the prior quarter.
- The five-year high for Cash from Discontinued Operations was 96000.0 in Q3 2012, with the low at 1589000.0 in Q3 2011.
- Historically, Cash from Discontinued Operations has averaged 575555.56 across 3 years, with a median of 281000.0 in 2011.
- Annual changes were most pronounced in 2011 — Cash from Discontinued Operations soared 55.11% — and 2012, when it soared 106.04%.
- Opko Health's Cash from Discontinued Operations stood at 626000.0 in 2010, then soared by 55.11% to 281000.0 in 2011, then soared by 97.51% to 7000.0 in 2012.
- The last three Cash from Discontinued Operations figures came in at 7000.0 (Q4 2012), 96000.0 (Q3 2012), and 157000.0 (Q2 2012), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | - |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | - |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | - |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | - |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | - |
| 10 | Opko Health | 1.09 Bn | 747.11 Mn | 45.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | -7,000.00 |
| Dec 31, 2012 | -7,000.00 |
| Sep 30, 2012 | 96,000.00 |
| Sep 30, 2012 | 96,000.00 |
| Jun 30, 2012 | -157,000.00 |
| Jun 30, 2012 | -157,000.00 |
| Mar 31, 2012 | 75,000.00 |
| Mar 31, 2012 | 75,000.00 |
| Dec 31, 2011 | -281,000.00 |
| Dec 31, 2011 | -281,000.00 |
| Sep 30, 2011 | -1.59 Mn |
| Sep 30, 2011 | -1.59 Mn |
| Jun 30, 2011 | -1.11 Mn |
| Jun 30, 2011 | -1.11 Mn |
| Mar 31, 2011 | -1.59 Mn |
| Mar 31, 2011 | -1.59 Mn |
| Dec 31, 2010 | -626,000.00 |
| Dec 31, 2010 | -626,000.00 |